Researchers say more work is needed to create calculators that predict fracture risk in individual patients with diabetes.
More diabetes, more obesity, and an aging population have added up to an increased risk for hip fractures, yet little is being done to find out which patients face this risk or even study the problem, according to a new review article.
A report in the journal Calcified Tissue International & Musculoskeletal Research examined the epidemiology of fractures in diabetes, and made recommendations for today’s doctors and for future studies. People with type 2 diabetes are 1.3 times more likely to have a hip fracture, and the risk is 7 times greater for those with type 1 diabetes.
But despite this, most doctors treating patients with diabetes never assess an individual patient for fracture with a bone mineral density test, according to the authors. The authors of the article, “Epidemiology of Fractures in Diabetes,” looks at current data on various risk factors that influence fracture risk, including age, gender, fracture history, smoking and alcohol use, risk of falls, glucocorticoid steroid use, pancreatitis, and autoimmune disease.
The authors say more work is needed to better understand the links between fractures and diabtes, and especially to develop better risk calculators for fracture. Current tools may not accurately predict which individual patients with diabetes will experience them. Spine imaging may help, and fall prevention strategies may be recommended for patients. The best course is good long-term management of the disease itself, which prevents hypoglycemic events and reduces the risk of neuropathy and retinopathy.
“Given that the global burden of both diabetes (currently 400 million people) and osteoporosis (currently 250 million) is expected to increase dramatically in the coming years, it is important that effective screening and prevention strategies are developed to reduce the risk of potentially devastating fractures in people with diabetes,” said the paper’s senior author, Professor Bo Abrahamsen, of the Department of Medicine, Holbaek Hospital, in Denmark.
Reference
Starup-Linde J, Frost M, Vestergaard P, Abrahamsen B, Epidemiology of fractures in diabetes [published October 17, 2016]. Calcif Tissue Int. 2016; doi:10.1007/s00223-016-0175-x.
Beyond Insulin: The Impact of Next-Generation Diabetes Technology
April 17th 2024Experts explain how new diabetes technologies like continuous glucose monitors are transforming care beyond intensive insulin therapy, offering personalized insights and improving outcomes for patients of all treatment levels.
Read More
How Can Employers Leverage the DPP to Improve Diabetes Rates?
February 15th 2022On this episode of Managed Care Cast, Jill Hutt, vice president of member services at the Greater Philadelphia Business Coalition on Health, explains the Coalition’s efforts to reduce diabetes rates through the Diabetes Prevention Program (DPP).
Listen
Balancing Care Access and Fragmentation for Better Outcomes in Veterans With Diabetes
April 22nd 2021The authors of a study in the April 2021 issue of The American Journal of Managed Care® discuss the possible reasons behind the link between care fragmentation and hospitalizations in veterans with diabetes, as well as potential opportunities to address disjointed care in the context of the widespread telehealth uptake seen during the COVID-19 pandemic.
Listen